Reported Consolidated quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 93.86 crore in December 2024 up 84.78% from Rs. 50.79 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 40.38 crore in December 2024 down 65.94% from Rs. 24.33 crore in December 2023.
EBITDA stands negative at Rs. 3.83 crore in December 2024 up 78.01% from Rs. 17.42 crore in December 2023.
Astec Life shares closed at 914.30 on January 24, 2025 (NSE) and has given -27.83% returns over the last 6 months and -4.66% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 93.86 | 98.55 | 50.79 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 93.86 | 98.55 | 50.79 | | EXPENDITURE | | Consumption of Raw Materials | 63.31 | 66.38 | 43.17 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.73 | 13.85 | -7.85 | | Power & Fuel | -- | -- | -- | | Employees Cost | 15.52 | 14.93 | 14.43 | | Depreciation | 11.40 | 11.47 | 8.70 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 22.50 | 23.12 | 19.38 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -17.14 | -31.21 | -27.03 | | Other Income | 1.91 | 2.00 | 0.91 | | P/L Before Int., Excpt. Items & Tax | -15.23 | -29.21 | -26.12 | | Interest | 9.92 | 9.33 | 6.09 | | P/L Before Exceptional Items & Tax | -25.15 | -38.54 | -32.22 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -25.15 | -38.54 | -32.22 | | Tax | 15.22 | 0.01 | -7.89 | | P/L After Tax from Ordinary Activities | -40.37 | -38.55 | -24.33 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -40.37 | -38.55 | -24.33 | | Minority Interest | -0.01 | -0.01 | -0.01 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -40.38 | -38.56 | -24.33 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -20.59 | -19.66 | -12.41 | | Diluted EPS | -20.59 | -19.66 | -12.41 | | EPS After Extra Ordinary | | Basic EPS | -20.59 | -19.66 | -12.41 | | Diluted EPS | -20.59 | -19.66 | -12.41 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
